Efficacy trial of ingestion of the development code MSHFS001. - Efficacy trial of ingestion of the development code MSHFS001.

Kao Corporation0 个研究点目标入组 82 人开始时间: 2018年9月13日最近更新: 2023年10月17日

适应症

试验速览

The results show that continuous intake of CGAs resulted in improvements in menopausal symptoms, especially hot flushes, in healthy women.

•-Subjects who have been suffered from disease. -Subjects who regularly take medicine. -Subjects who are undergoing medical treatment or were treated by doctor within a month. -Subjects who are under hormone replacement therapy (HRT), and / or subjects who are in medication that affect blood hormone levels. -Subjects who regularly take supplements related to menopausal symptoms. -Subjects who regularly take functional food and/or supplements related to sleep. -Subjects who are pregnant, lactating, or planned to become pregnant during the test period. -Subjects with smoking habit. -Subjects who cannot follow the restriction of eating habit. -Subjects who have possibilities for emerging allergy to foods, metals, and drugs. -Subjects who are shift workers. -Subjects deemed inappropriate to participate in this study by the principle investigator.

发起方